Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

BUY
$323.56 - $373.36 $386,654 - $446,165
1,195 New
1,195 $446,000
Q4 2021

Feb 02, 2022

SELL
$373.53 - $434.12 $2.61 Million - $3.03 Million
-6,978 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$396.76 - $455.92 $167,035 - $191,942
421 Added 6.42%
6,978 $2.88 Million
Q2 2021

Aug 11, 2021

BUY
$372.36 - $412.07 $78,567 - $86,946
211 Added 3.32%
6,557 $2.6 Million
Q1 2021

May 10, 2021

SELL
$357.26 - $392.57 $1.24 Million - $1.36 Million
-3,465 Reduced 35.32%
6,346 $2.44 Million
Q4 2020

Feb 11, 2021

BUY
$319.05 - $363.32 $304,054 - $346,243
953 Added 10.76%
9,811 $3.57 Million
Q3 2020

Nov 10, 2020

BUY
$280.08 - $347.78 $765,738 - $950,830
2,734 Added 44.64%
8,858 $2.99 Million
Q2 2020

Aug 13, 2020

SELL
$270.93 - $320.3 $10,566 - $12,491
-39 Reduced 0.63%
6,124 $1.74 Million
Q1 2020

Apr 30, 2020

BUY
$243.44 - $359.98 $428,454 - $633,564
1,760 Added 39.97%
6,163 $1.7 Million
Q4 2019

Jan 31, 2020

BUY
$281.18 - $322.05 $250,531 - $286,946
891 Added 25.37%
4,403 $1.42 Million
Q3 2019

Nov 08, 2019

BUY
$294.25 - $341.49 $122,996 - $142,742
418 Added 13.51%
3,512 $1.04 Million
Q2 2019

Aug 07, 2019

BUY
$279.29 - $336.89 $864,123 - $1.04 Million
3,094 New
3,094 $1.04 Million
Q4 2018

Jan 31, 2019

SELL
$232.7 - $281.66 $722,766 - $874,835
-3,106 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$218.74 - $251.43 $139,337 - $160,160
-637 Reduced 17.02%
3,106 $711,000
Q4 2017

Feb 09, 2018

BUY
$217.88 - $244.43 $138,789 - $155,701
637 Added 20.51%
3,743 $816,000
Q3 2017

Nov 07, 2017

SELL
$231.6 - $253.39 $75,038 - $82,098
-324 Reduced 9.45%
3,106 $736,000
Q2 2017

Aug 09, 2017

BUY
N/A
3,430
3,430 $821,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.